These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23809058)

  • 1. 3D matched pairs: integrating ligand- and structure-based knowledge for ligand design and receptor annotation.
    Posy SL; Claus BL; Pokross ME; Johnson SR
    J Chem Inf Model; 2013 Jul; 53(7):1576-88. PubMed ID: 23809058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based virtual screening approach to the discovery of p38 MAP kinase inhibitors.
    Choi H; Park HJ; Shin JC; Ko HS; Lee JK; Lee S; Park H; Hong S
    Bioorg Med Chem Lett; 2012 Mar; 22(6):2195-9. PubMed ID: 22342625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based identification of small molecule binding sites using a free energy model.
    Coleman RG; Salzberg AC; Cheng AC
    J Chem Inf Model; 2006; 46(6):2631-7. PubMed ID: 17125203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions.
    Deng Z; Chuaqui C; Singh J
    J Med Chem; 2004 Jan; 47(2):337-44. PubMed ID: 14711306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid molecules induce p38α activation via a novel molecular switch.
    Tzarum N; Eisenberg-Domovich Y; Gills JJ; Dennis PA; Livnah O
    J Mol Biol; 2012 Dec; 424(5):339-53. PubMed ID: 23079240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring protein kinase conformation using swarm-enhanced sampling molecular dynamics.
    Atzori A; Bruce NJ; Burusco KK; Wroblowski B; Bonnet P; Bryce RA
    J Chem Inf Model; 2014 Oct; 54(10):2764-75. PubMed ID: 25178116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid identification of ligand-binding sites by using an assignment-free NMR approach.
    Kodama Y; Takeuchi K; Shimba N; Ishikawa K; Suzuki E; Shimada I; Takahashi H
    J Med Chem; 2013 Nov; 56(22):9342-50. PubMed ID: 24171460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The third conformation of p38α MAP kinase observed in phosphorylated p38α and in solution.
    Akella R; Min X; Wu Q; Gardner KH; Goldsmith EJ
    Structure; 2010 Dec; 18(12):1571-8. PubMed ID: 21134636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VAMMPIRE: a matched molecular pairs database for structure-based drug design and optimization.
    Weber J; Achenbach J; Moser D; Proschak E
    J Med Chem; 2013 Jun; 56(12):5203-7. PubMed ID: 23734609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based quantitative structure--activity relationship modeling of estrogen receptor β-ligands.
    Dong X; Hilliard SG; Zheng W
    Future Med Chem; 2011 Jun; 3(8):933-45. PubMed ID: 21707397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docking ligands onto binding site representations derived from proteins built by homology modelling.
    Schafferhans A; Klebe G
    J Mol Biol; 2001 Mar; 307(1):407-27. PubMed ID: 11243828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comprehensive Structural Overview of p38α Mitogen-Activated Protein Kinase in Complex with ATP-Site and Non-ATP-Site Binders.
    Astolfi A; Manfroni G; Cecchetti V; Barreca ML
    ChemMedChem; 2018 Jan; 13(1):7-14. PubMed ID: 29210532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for the high-affinity binding of pyrrolotriazine inhibitors of p38 MAP kinase.
    Sack JS; Kish KF; Pokross M; Xie D; Duke GJ; Tredup JA; Kiefer SE; Newitt JA
    Acta Crystallogr D Biol Crystallogr; 2008 Jul; D64(Pt 7):705-10. PubMed ID: 18566506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of a nitrogen-sulfur nonbonding interaction in the design of new 2-aminothiazol-5-yl-pyrimidines as p38α MAP kinase inhibitors.
    Lin S; Wrobleski ST; Hynes J; Pitt S; Zhang R; Fan Y; Doweyko AM; Kish KF; Sack JS; Malley MF; Kiefer SE; Newitt JA; McKinnon M; Trzaskos J; Barrish JC; Dodd JH; Schieven GL; Leftheris K
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5864-8. PubMed ID: 20732813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of protein-ligand interaction fingerprints in docking.
    Brewerton SC
    Curr Opin Drug Discov Devel; 2008 May; 11(3):356-64. PubMed ID: 18428089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenesis of p38alpha MAP kinase establishes key roles of Phe169 in function and structural dynamics and reveals a novel DFG-OUT state.
    Bukhtiyarova M; Karpusas M; Northrop K; Namboodiri HV; Springman EB
    Biochemistry; 2007 May; 46(19):5687-96. PubMed ID: 17441692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of 3D-QSAR in the rational design of receptor ligands and enzyme inhibitors.
    Mor M; Rivara S; Lodola A; Lorenzi S; Bordi F; Plazzi PV; Spadoni G; Bedini A; Duranti A; Tontini A; Tarzia G
    Chem Biodivers; 2005 Nov; 2(11):1438-51. PubMed ID: 17191945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of 6-anilinoindazoles as selective inhibitors of c-Jun N-terminal kinase-3.
    Swahn BM; Huerta F; Kallin E; Malmström J; Weigelt T; Viklund J; Womack P; Xue Y; Ohberg L
    Bioorg Med Chem Lett; 2005 Nov; 15(22):5095-9. PubMed ID: 16140012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indolin-2-one p38α inhibitors I: design, profiling and crystallographic binding mode.
    Eastwood P; González J; Gómez E; Vidal B; Caturla F; Roca R; Balagué C; Orellana A; Domínguez M
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4130-3. PubMed ID: 21696951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A searchable database for comparing protein-ligand binding sites for the analysis of structure-function relationships.
    Gold ND; Jackson RM
    J Chem Inf Model; 2006; 46(2):736-42. PubMed ID: 16563004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.